NCT01514227

Nobori Dual Antiplatelet Therapy as Appropriate Duration

Nobori Dual Antiplatelet Therapy as Appropriate Duration.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 3,773 (actual)
• Sponsor: Associations for Establishment of Evidence in Interventions · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

NIPPON trial is a prospective, randomized, trial comparing 6 and 18 months Dual Antiplatelet Therapy (DAPT) following Nobori stent deployment.

Conditions

• Coronary Artery Disease

Interventions

Type	Name	Description
DRUG	Aspirin or thienopyridine	Subjects randomized 6 month DAPT will be prescribed either aspirin or thienopyridine (clopidogrel or ticlopidine) following 6 months DAPT for the duration of study, which is left on the physician's discretion.
DRUG	Aspirin and thienopyridine	Subjects randomized 18 month DAPT will be prescribed both aspirin and thienopyridine (clopidogrel or ticlopidine) for 18 month after stenting.

Timeline

• Start date: 2011-12-01
• Primary completion: 2016-06-01
• Completion: 2016-06-01
• First posted: 2012-01-23
• Last updated: 2017-01-27

Locations

1 site across 1 country: Japan